Future studies should explore the precise molecular interactions between melatonin and autophagy regulators to fully elucidate its role in pancreatic cancer therapy and explore the specific role of P62-mediated autophagy in the context of PC to better understand its therapeutic implications. This evidence concerns the gene SQSTM1 and pachyonychia congenita.